GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd (SHSE:600329) » Definitions » Other Gross PPE

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Other Gross PPE : ¥1,043 Mil (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Tianjin Pharmaceutical Da Ren Tang Group Other Gross PPE?

Tianjin Pharmaceutical Da Ren Tang Group's Other Gross PPE for the quarter that ended in Mar. 2024 was ¥1,043 Mil.

Tianjin Pharmaceutical Da Ren Tang Group's quarterly Other Gross PPE increased from Sep. 2023 (¥1,063 Mil) to Dec. 2023 (¥1,499 Mil) but then declined from Dec. 2023 (¥1,499 Mil) to Mar. 2024 (¥1,043 Mil).

Tianjin Pharmaceutical Da Ren Tang Group's annual Other Gross PPE increased from Dec. 2021 (¥1,519 Mil) to Dec. 2022 (¥1,535 Mil) but then declined from Dec. 2022 (¥1,535 Mil) to Dec. 2023 (¥1,499 Mil).


Tianjin Pharmaceutical Da Ren Tang Group Other Gross PPE Historical Data

The historical data trend for Tianjin Pharmaceutical Da Ren Tang Group's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tianjin Pharmaceutical Da Ren Tang Group Other Gross PPE Chart

Tianjin Pharmaceutical Da Ren Tang Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,486.26 1,526.77 1,519.02 1,534.91 1,499.34

Tianjin Pharmaceutical Da Ren Tang Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,105.97 1,534.58 1,062.87 1,499.34 1,042.70

Tianjin Pharmaceutical Da Ren Tang Group Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Business Description

Traded in Other Exchanges
Address
No. 17 Baidi Road, Zhong Xin Mansion, Nankai District, Tianjin, CHN, 300193
Tianjin Pharmaceutical Da Ren Tang Group Corp Ltd is a pharmaceutical manufacturing company. The company manufactures and sells traditional Chinese medicine, western medicine, and healthcare products in the People's Republic of China. It operates in two segments namely The Chinese Medicine segment and The Western Medicine segment. The Chinese Medicine segment manufactures Chinese pharmaceutical products under brands owned by the group. The Western Medicine segment manufactures western pharmaceutical products through cooperation with foreign companies. The company earns the majority of its revenue from the sale of Chinese pharmaceutical products.
Executives
Li Li Qun Director
Ni Zhen Guo senior management
Yu Hong Directors, senior managers
Zhou Hong Directors, senior managers
Zhang Jian senior management
Niu Sheng Fang senior management
Wang Xin senior management
Wang Mai Director
Jiao Yan senior management
Hao Fei Fei Director
Zhang Bao Tong senior management
Wang Zhi Qiang senior management
Liang Xiu Qin senior management
Li Jia Sheng Supervisors
Zhang Hong Kui Director

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Headlines

No Headlines